TQ0064 |
Peretinoin
|
81485-25-8
|
99.86%
|
|
Peretinoin (NIK333) is an oral acyclic retinoid with a vitamin A-like structure that targets retinoid nuclear receptors such as RXR and RAR.
|
T17029 |
Tegobuvir
|
1000787-75-6
|
99.86%
|
|
Tegobuvir (GS 333126) is a specific and covalent HCV NS5B polymerase inhibitor.
|
T2162 |
Maribavir
|
176161-24-3
|
99.85%
|
|
Maribavir (GW257406X) is an orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor...
|
T5396 |
Letermovir
|
917389-32-3
|
99.85%
|
|
Letermovir (AIC246) (AIC246) is a novel anti-CMV compound (EC50: about 5 nM in fibroblast cells). It targets the pUL56 subunit of the viral terminase complex.
|
T1786 |
Daclatasvir dihydrochloride
|
1009119-65-6
|
99.84%
|
|
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and ...
|
T19862 |
Voxilaprevir
|
1535212-07-7
|
99.83%
|
|
Voxilaprevir is an inhibitor of hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease.
|
T17190 |
U18666A
|
3039-71-2
|
99.83%
|
|
U18666A is a cell-permeable drug and is a cholesterol synthesis and transport inhibitor. It inhibits replication of Ebola virus, dengue virus, and human hepatiti...
|
T6676 |
Sofosbuvir
|
1190307-88-0
|
99.82%
|
|
Sofosbuvir (GS 7977) is a uridine monophosphate analog inhibitor of hepatitis C virus (HCV) polymerase NS5B that is used as an antiviral agent in the treatment o...
|
T0684 |
Ribavirin
|
36791-04-5
|
99.82%
|
|
Ribavirin (Tribavirin) is a synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses.
|
T6229 |
Daclatasvir
|
1009119-64-5
|
99.81%
|
|
Daclatasvir (EBP 883) (BMS-790052) is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 ge...
|
T2770 |
Gentiopicroside
|
20831-76-9
|
99.8%
|
|
Gentiopicroside (Gentiopicrin), a naturally occurring iridoid glycoside, extracted from Gentiana manshurica Kitag, inhibits P450 activity, with an IC50 and a Ki ...
|
TN5263 |
1-[2,4-Dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one
|
569-83-5
|
99.79%
|
|
1-[2,4-Dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one (Xanthohumol) , prenylchacone flavonoid, is a natural product with...
|
T6964 |
Resiquimod
|
144875-48-9
|
99.78%
|
|
Resiquimod (R848) is an imidazoquinoline amine and Toll-like receptor (TLR) agonist with potential immune response modifying activity. Resiquimod exerts its effe...
|
T4686 |
Simeprevir
|
923604-59-5
|
99.77%
|
|
Simeprevir (TMC435) is a potent HCV NS3/4A protease inhibitor, and inhibits HCV replication with EC50 of 8 nM.
|
T9331 |
Bemnifosbuvir hemisulfate
|
2241337-84-6
|
99.74%
|
|
Bemnifosbuvir hemisulfate (AT-527) is a potent inhibitor of HCV virus replication.
|
T4544 |
Elbasvir
|
1370468-36-2
|
99.7%
|
|
Elbasvir (MK-8742) is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic...
|
T9341 |
Bemnifosbuvir
|
1998705-64-8
|
99.69%
|
|
Bemnifosbuvir (AT-511) is a novel phosphoramidate prodrug of 2'-fluoro-2'-C-methylguanosine-5'-monophosphate that has potent in vitro activity against HCV.
|
T15282 |
Filibuvir
|
877130-28-4
|
99.68%
|
|
Filibuvir (PF-00868554) is a selective and noncovalent inhibitor of HCV NS5B RNA-dependent RNA polymerase. Filibuvir inhibits genotype 1a and 1b replicons with E...
|
TQ0162 |
R-1479
|
478182-28-4
|
99.68%
|
|
R-1479 (4'-Azidocytidine) is an RdRp inhibitor with an IC50 value of 1.28 μM for HCV RNA replication in the HCV subgenomic replicon system.
|
T11539 |
HCV-IN-29
|
1009119-83-8
|
99.66%
|
|
HCV-IN-29 is a hepatitis C virus (HCV) inhibitor.
|